Open access
72
Views
0
CrossRef citations to date
0
Altmetric
Review
Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib
Yuanqiong Hu1 MSF Access Campaign,Médecins Sans Frontières,Rue de Lausanne 78,P. O Box 1016,CH-1211Geneva 1,Switzerland.;2 School of Law, School of Oriental and African Studies (SOAS),University of London,Russell Square, 10 Thornhaugh Street, Russell Square,LondonWC1H OXG,UK.
, Dimitri Eynikel1 MSF Access Campaign,Médecins Sans Frontières,Rue de Lausanne 78,P. O Box 1016,CH-1211Geneva 1,Switzerland.Correspondence[email protected]
https://orcid.org/0000-0001-6894-3257
Pascale Boulet4 Medicines Law & Policy,105 route de Lossiège,74130Contamine sur Arve,France.
& Gaelle Krikorian1 MSF Access Campaign,Médecins Sans Frontières,Rue de Lausanne 78,P. O Box 1016,CH-1211Geneva 1,Switzerland.
Article: 1
|
Received 16 Aug 2018, Accepted 14 Nov 2019, Published online: 04 Dec 2023
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.